Why it was recalled
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Product description
Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 300025, NDC 42192-113-60
Lot numbers, UPCs & expiration codes
Lot#: 21084, 21085, Exp 06/30/2023
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0074-2023
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Nov 14, 2022
- FDA report date
- Dec 7, 2022
- Quantity
- 528 cartons
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Acella Pharmaceuticals, LLC
Original FDA data
Every field from FDA enforcement report D-0074-2023, exactly as published.
Show all FDA fields
- City
- Alpharetta
- State
- GA
- Status
- Terminated
- Country
- United States
- Event ID
- 91150
- Address
- 1880 Mcfarland Pkwy Ste 110
- Code information
- Lot#: 21084, 21085, Exp 06/30/2023
- Postal code
- 30005-1795
- Report date
- Dec 7, 2022
- Product type
- Drugs
- Recall number
- D-0074-2023
- Classification
- Class III
- Recalling firm
- Acella Pharmaceuticals, LLC
- Product quantity
- 528 cartons
- Termination date
- Aug 1, 2024
- Reason for recall
- Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 300025, NDC 42192-113-60
- Distribution pattern
- USA Nationwide
- Recall initiation date
- Nov 14, 2022
- Initial firm notification
- Letter
- Center classification date
- Dec 1, 2022